TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Hofseth BioCare ASA
Closing information (x1000 SEK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
188,360
|
125,940
|
78,831 |
| Financial expenses |
13,122
|
13,887
|
11,872 |
| Earnings before taxes |
-105,312
|
-145,246
|
-129,677 |
| Total assets |
385,100
|
434,533
|
426,542 |
| Current assets |
129,317
|
185,798
|
174,638 |
| Current liabilities |
248,637
|
182,076
|
154,768 |
| Equity capital |
40,611
|
156,494
|
143,945 |
| - share capital |
3,900
|
4,177
|
3,669 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
10.5%
|
36.0%
|
33.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-55.9%
|
-115.3%
|
-164.5% |
| Return on assets (ROA) |
-23.9%
|
-30.2%
|
-27.6% |
| Current ratio |
52.0%
|
102.0%
|
112.8% |
| Return on equity (ROE) |
-259.3%
|
-92.8%
|
-90.1% |
| Change turnover |
70,765
|
44,666
|
24,983 |
| Change turnover % |
60%
|
55%
|
46% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.